Biography
Cristina has more than 15 years of biotech experience, beginning with Antigenics (now Agenus), a cancer immunotherapy company, where she worked many years at the bench to then move into clinical. She then joined Biogen where for the past 8 years, she’s been in the clinical development teamworking on a BDCA-2 antibody treatment for cutaneous lupus erythematosus whose results were recently published in the New England Journal of Medicine. She is currently the Head of Clinical Development, Senior Medical Director at Abata where she is supporting the development of autologous engineered Tregs for the therapy of MS.
Track Chair: Sharon Benzeno, Adaptive Biotechnologies